Whether it’s about your visit, the care you received, or our customer service.
Want to contribute to the next phase of PrEP Research?
The Injectable PrEP study is testing a new form of PrEP. Participants will receive an injection every 8 weeks to determine if injectable Cabotegravir is as effective as daily oral Truvada for PrEP at preventing HIV infection. We are looking for 18+ year old, HIV uninfected transwomen and men who have sex with men. Participants will be compensated for their time.
For more information please call 617.927.6450 or email InjectablePrEP@fenwayhealth.org
Please click here to take an online screener to see if you may be eligible.